ChiRhoClin, Inc., a Maryland based family run corporation, was founded in 1991 by CEO, Edward D. Purich, Ph.D.ChiRhoClin is a research and development oriented pharmaceutical company focused on the development of peptide and protein based drug products.Our mission is to develop orphan drug products for the GI and Radiological community.Our emphasis is to develop orphan drug products that will diagnose and treat pancreatic gastrointestinal diseases and to encourage research in the pancreatic area through our small grant program.

ChiRhoClin, Inc. received approval from the FDA on April 5th, 2002 to manufacture and market Synthetic Porcine Secretin. Two years later, ChiRhoClin received approval from the FDA on April 9th, 2004 to manufacture and market ChiRhoStim® (Synthetic Human Secretin for injection).